• Our Approach

    At Pharmacyclics, our patients motivate and inspire us to push the boundaries of science. We strive to make a difference in their lives. It’s not only our mission, but our passion.

Patient-first. Science-based. Employee-driven.

Our charge is to help people impacted by cancer and immune-mediated diseases to effectively and safely treat their disease. We do this with an industry leading R&D team based in Silicon Valley and collaboratively with AbbVie. Our combined R&D teams are passionate about discovering the next-generation medicines that keep changing the standard of healthcare and continuing research efforts to make current treatments even better. We will know that our mission has been achieved when patients and their families have rediscovered the Magic of Normal – where disease no longer defines the every day.

Grounded in our Ways We Work culture that defines the team work and behavior necessary for our collective success, we are building an environment that celebrates agile innovation, a shared organizational mission, and provides a personally fulfilling and professionally rewarding experience. This support our employees give to one another and the cross-functional partnerships that are forged help us exceed our goals.

IMBRUVICA®

For more information on IMBRUVICA® (ibrutinib), a Bruton's tyrosine kinase (BTK) inhibitor, please visit: www.imbruvica.com

Patient Support

We are committed to providing support to help patients learn about access to IMBRUVICA® (ibrutinib), receive information on support options, and sign up for information and resources to support them on their treatment journey.

Postmarketing Commitments

Postmarketing Commitment studies build upon the data that was submitted for regulatory approvals with the intent to gather additional information about that product’s safety, effectiveness, and/or optimal use.